Target intelligence / Profile preview

MIR9-2 host gene (MIR9-2HG)

Target
MIR9-2HG
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

MIR9-2 host gene (MIR9-2HG) is an evolutionarily conserved long non-coding RNA (lncRNA) gene that produces alternatively spliced non-coding transcripts and is widely expressed, including in neural tissues[3]. It is orthologous to the human gene in several model organisms and is part of a genomic region associated with neural development and differentiation. Although the MIR9-2 microRNA gene lies adjacent and may have a regulatory link, MIR9-2HG itself is not a well-established therapeutic target such as a receptor, enzyme, or transporter, and does not encode a protein[4][5][6]. It has been associated with some disease contexts (e.g., benign neoplasms), but its precise biological functions and disease mechanisms remain only partially characterized[4]. If structured target information for therapeutic development, druggability, biomarkers, or mechanisms of action is needed, note that MIR9-2HG does not fit the conventional criteria for a therapeutic target at this time[4][5][6].

Other names
EyeLinc1ViscLOC645323ECONEXINNDIMELINC00461LINC02060lincRNA 461long intergenic non-protein coding RNA 2060long intergenic non-protein coding RNA 461neural differentiation initiation of MEF2C expressionCTC-498M16.2visual cortex expressedvisual cortex-expressed
02

Biological functions

Potential regulation of gene expressionMay influence neural development and differentiationProduces alternatively spliced lncRNAs[3][4]
03

Disease associations

Cancer (including rectal benign neoplasm)[4]Possibly neurodevelopmental and neural tissue roles (inferred from expression and gene context)[3][5]

Beyond the preview

Go deeper on MIR9-2 host gene (MIR9-2HG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIR9-2 host gene (MIR9-2HG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call